Navigate risk with greater precision
In-Depth Forecasting from the pharmaceutical and biotechnology expert
Creating clarity is what we do
Deep industry expertise ensures that your forecasts are comprehensive, dynamic, and clear
Forecasting will always be complex – that’s why you need a specialist
As your trusted partner, we’ll put our therapeutic expertise to work for you
Trusted by leading life science companies
Specialists in forecasting for pharmaceutical and biotechnology markets
Delivering integrated U.S. and global models for:
Business Development
& Licensing
Inform major decisions quickly and effectively before the window of opportunity closes.
On-Market
Products
Achieve the accuracy and versatility needed to drive confidence with stakeholders.
When your forecasting needs call for more breadth and depth – choose Viscadia
Viscadia is a leading global forecasting firm specializing in the pharmaceutical and biotechnology industries — with models that integrate U.S. and global forecasts. We capitalize on decades of corporate pharmaceutical experience to design and build models that are:
Comprehensive
Ensuring that forecasts meet the cross-functional needs of Commercial, Finance, and Business Development stakeholders
Dynamic
Designing and building models that evolve and grow with your products and markets
Clear
Delivering forecasting models and processes that provide you with the clarity you need
Our international presence allows us to provide rapid access to innovative problem-solving and expert analysis — when you need it, where you need it — so you will always receive your forecasts on time.
“Viscadia brought additional dimensions to the existing forecast, which aided buy-in from our stakeholders. I needed someone to work alongside me, and they were the ideal partner.”
Rob Hernandez
Associate Director, Forecasting & Financial Planning
Daiichi Sankyo
“Viscadia has been a long-term strategic partner to Milestone on the forecasting front. In addition to their responsiveness and innovative modeling techniques, they have deep therapeutic expertise which enables us to expand our own thinking and ultimately make more informed decisions.”
Lorenz Muller
Chief Commercial Officer
Milestone Pharmaceuticals
“Our forecast was accurate… that was a critical piece of allowing us to complete a successful and valuable acquisition.”
Josh Franklin
Chief Commercial Officer,
Pharmacosmos Therapeutics, Inc.
Our forecasts have helped clients drive value at every step of the product journey:
10 Years and Counting
In 2020 we celebrated an important milestone — a full decade of high quality, client-centered service. We look forward to celebrating many more years of strong collaboration with our clients.
Watch the Video
